The Ongoing Opioid Litigation & Its Impact on the Pharmaceutical Industry
April 22, 2021 11:00am-1:00pm
Pending Approval for 2 Standard CLE Credits
The opioid crisis continues to have a profound and devastating impact on the public’s health. The crisis, and the litigation spawned by it, have far-reaching impacts on patients and the pharmaceutical industry. Speakers will highlight the lessons learned from recent cases and settlements, as well as the impact on companies committed to taking an ethical and compliant approach to developing, manufacturing, and marketing prescription opioid products.
President & CEO, Whitelaw Compliance Group, LLC.
Senior Fellow & Adjunct Professor, Life Sciences Compliance
Mitchell Hamline School of Law
Editor, Policy & Medicine Compliance Update
General Counsel & Chief Compliance Officer of Sentynl Therapeutics
12:30-1pmRegister – Individual Event